SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-05-002557
Filing Date
2005-09-09
Accepted
2005-09-09 16:45:40
Documents
4
Period of Report
2005-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR PERIOD ENDED JULY 31, 2005 peregrine_10q073105.htm 10-Q 604427
2 CERTIFICATION peregrine_10qex3101.htm EX-31.1 11351
3 CERTIFICATION peregring_10qex3102.htm EX-31.2 11302
4 CERTIFICATION peregrine_10qex32.htm EX-32 8978
  Complete submission text file 0001019687-05-002557.txt   637658
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17085 | Film No.: 051078185
SIC: 2835 In Vitro & In Vivo Diagnostic Substances